Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Apr;26(3):297-300.
doi: 10.1385/ENDO:26:3:297.

Ovarian aging and the perimenopausal transition: the paradox of endogenous ovarian hyperstimulation

Affiliations
Review

Ovarian aging and the perimenopausal transition: the paradox of endogenous ovarian hyperstimulation

Jerilynn C Prior. Endocrine. 2005 Apr.

Abstract

The purpose of this review is to put into a useful clinical context the changing over time of basic ovarian-pituitary-hypothalamic relationships during perimenopause. "Perimenopause" means changes in ovarian hormones, feedback relationships, and clinical experiences beginning in women ages 35-50 with regular flow and ending 1 yr after the final menstrual flow. A key observation must be explained--estradiol levels are increased in perimenopause. Inhibin B levels are lower and activin may be higher in midlife, menstruating women. These changes probably cause higher follicular phase FSH levels--"endogenous ovarian hyperstimulation" results. The positive estradiol feedback on LH is also disturbed--midcycle LH peaks and mid-luteal slow-frequency, high-amplitude LH pulses are less frequent. In addition to higher levels, estradiol receptors may increase in tissues of symptomatic women. Despite hyperstimulation of follicles, progesterone levels and luteal phase lengths are paradoxically decreased--reasons probably include LH peak disruptions and estrogen-stimulated greater corticotrophin-mediated reproductive suppression. In summary, disturbed feedback relationships causing higher and unpredictable estrogen and lower progesterone levels occur throughout perimenopause, especially during regular cycles. Prospective, population-based research is needed to systematically relate these feedback hormonal changes to clinical characteristics and to allow a diagnosis of perimenopause in regularly cycling midlife women.

PubMed Disclaimer

References

    1. J Clin Endocrinol Metab. 1999 Jan;84(1):105-11 - PubMed
    1. Menopause. 1998 Spring;5(1):43-51 - PubMed
    1. Am J Physiol. 1997 May;272(5 Pt 1):E885-91 - PubMed
    1. Reprod Fertil Dev. 1990;2(3):205-18 - PubMed
    1. Clin Endocrinol (Oxf). 1994 Jun;40(6):717-23 - PubMed

LinkOut - more resources